Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Zhi-Ran Yang"'
Autor:
Yan-Dong Su, Xin Zhao, Ru Ma, Yu-Bin Fu, Zhi-Ran Yang, He-Liang Wu, Yang Yu, Rui Yang, Xin-li Liang, Xue-Mei Du, Yue Chen, Yan Li
Publikováno v:
International Journal of Hyperthermia, Vol 40, Iss 1 (2023)
AbstractObjectives To establish a Bayesian network (BN) model to predict the survival of patients with malignant peritoneal mesothelioma (MPM) treated with cytoreductive surgery (CRS) plus hyperthermic intraperitoneal chemotherapy (HIPEC).Methods The
Externí odkaz:
https://doaj.org/article/ee5273a47ed44db881e8113ca266a6d6
Autor:
Rui Yang, Yan-Dong Su, Gang Liu, Yang Yu, Xin-Bao Li, Xin Zhao, Zhong-He Ji, Ru Ma, Zhi-Ran Yang, Yu-Lin Lin, He-Liang Wu, Yan Li
Publikováno v:
International Journal of Hyperthermia, Vol 40, Iss 1 (2023)
AbstractObjective To investigate the effects of standardized fluid management (SFM) on cardiac function in patients with pseudomyxoma peritonei (PMP) after cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC).Method Patie
Externí odkaz:
https://doaj.org/article/81ab9f71a807413c98d7578f87408b1b
Publikováno v:
International Journal of Hyperthermia, Vol 39, Iss 1, Pp 706-712 (2022)
Objectives To investigate independent factors for the efficacy and safety of cytoreductive surgery (CRS) plus hyperthermic intraperitoneal chemotherapy (HIPEC) for the treatment of diffuse malignant peritoneal mesothelioma (DMPM).Methods The clinical
Externí odkaz:
https://doaj.org/article/b558c10c13294010ac94b970375c512a
Publikováno v:
World Journal of Surgical Oncology, Vol 20, Iss 1, Pp 1-9 (2022)
Abstract Background Malignant peritoneal mesothelioma (MPM) is a rare malignant tumor with a high mortality rate and extremely poor prognosis. In-depth pathological analysis is essential to assess tumor biological behaviors and explore potential ther
Externí odkaz:
https://doaj.org/article/80a16d7024444059bb395191de21e02a
Publikováno v:
World Journal of Surgical Oncology, Vol 20, Iss 1, Pp 1-9 (2022)
Abstract Background This review systematically summarizes gene biology features and protein structure of nucleoplasmin2 (NPM2) and the relationship between NPM2 and malignant peritoneal mesothelioma (MPM), in order to explore the molecular pathologic
Externí odkaz:
https://doaj.org/article/6b6610c0666d41c09b749b6d7d8f3fea
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
ObjectiveTo investigate the clinical efficacy and adverse events (AEs) of apatinib salvage treatment for diffuse malignant peritoneal mesothelioma (DMPM) that has failed to respond to the recommended treatments.Methods27 patients with refractory DMPM
Externí odkaz:
https://doaj.org/article/a4c0080c50d6440d94374446bac55baf
Autor:
Yu‐Lin Lin, Jue Zhang, Feng‐Cai Yan, Xi Jiang, Ru Ma, Zhi‐Ran Yang, Hong‐Bin Xu, Zheng Peng, Qian Chen, Yan Li
Publikováno v:
Cancer Medicine, Vol 9, Iss 3, Pp 1104-1114 (2020)
Abstract Background Pseudomyxoma peritonei (PMP) is an indolent malignancy and insensitive to systemic chemotherapy. The authors established patient‐derived xenograft (PDX) model of PMP, and evaluated the efficacy and toxicity of intraperitoneal (i
Externí odkaz:
https://doaj.org/article/c7307364506d48f9bab71dfbbf79be23
Publikováno v:
Frontiers in Oncology, Vol 10 (2020)
ObjectiveMalignant peritoneal mesothelioma (MPM) is a rare malignancy with few effective molecular therapies. In this study, we evaluated the anti-tumor activity and safety of apatinib, a vascular endothelial growth factor receptor 2 inhibitor, in MP
Externí odkaz:
https://doaj.org/article/6bd3049099ab435f963912d84afa04e0
Autor:
Zhi-Ran Yang, Zheng Peng, Qian Chen, Fengcai Yan, Yan Li, Hong-Bin Xu, Xi Jiang, Yulin Lin, Jue Zhang, Ru Ma
Publikováno v:
Cancer Medicine, Vol 9, Iss 3, Pp 1104-1114 (2020)
Cancer Medicine
Cancer Medicine
Background Pseudomyxoma peritonei (PMP) is an indolent malignancy and insensitive to systemic chemotherapy. The authors established patient‐derived xenograft (PDX) model of PMP, and evaluated the efficacy and toxicity of intraperitoneal (i.p.) admi
Autor:
Ru Ma, Zhong-He Ji, Zhi-Gao Chen, Zhao Li, Zhi-Ran Yang, Xi Jiang, Jue Zhang, Yulin Lin, Yan Li, Qian Chen, Xue-Mei Du
Publikováno v:
Experimental Animals
Background: Malignant peritoneal mesothelioma (MPM) is a rare malignancy with few effective therapies. This study established patient-derived xenograft (PDX) models and primary cell lines to provide a study platform for MPM in vitro and in vivo, and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::68720eeac887ff5e9ef878b384eb4896
https://doi.org/10.21203/rs.3.rs-45393/v1
https://doi.org/10.21203/rs.3.rs-45393/v1